Back to Citigroup Inc. Citigroup Inc.

SMMTSMMT

Showing 9 of 12 quarters

Position history for Citigroup Inc.Citigroup Inc.'s holdings in Summit Therapeutics Inc.

Yes. Citigroup holds 510,193 shares of SMMT (Summit Therapeutics), worth $8.6M, as of its Q3 2026 13F filing. It reduced the position by 203,807 shares (-28.5%) from Q2 2026. Citigroup has held SMMT in every 13F on record since Q4 2023, 12 quarterly filings.

Current Value

$8.6M

Current Shares

510,193

Total Value Change

+$7M

Total Shares Change

+434,058

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
510,193
-28.5%
$8.6M0.0%$16.91
0
2026-Q2
Increased
714,000
+258.6%
$10.4M0.0%$14.57
45
2026-Q1
Increased
199,133
+53.3%
$3.8M0.0%$18.96
37
2025-Q4
Decreased
129,926
-18.7%
$2.3M0.0%$17.49
0
2025-Q3
Increased
159,873
+41.1%
$3.3M0.0%$20.66
35
2025-Q2
Decreased
113,338
-61.6%
$2.4M0.0%$21.28
0
2025-Q1
Increased
295,415
+16.3%
$5.7M0.0%$19.29
31
2024-Q4
Increased
254,040
+233.7%
$4.5M0.0%$17.85
43
2024-Q3
Increased
76,135
+19.8%
$1.7M0.0%$21.90
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used